We are live on
!
Find out more
N
Nuveen Portfolio holdings
AUM
$369B
1-Year Est. Return
31.66%
This Fund
S&P 500
This Quarter
Est. Return
+9.78%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$258B
AUM Growth
+$11.2B
(+4.5%)
Cap. Flow
-$8.74B
Cap. Flow
% of AUM
-3.39%
Top 10 Holdings %
Top 10 Hldgs %
19.2%
Holding
3,329
New
40
Increased
1,011
Reduced
1,986
Closed
159
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Prologis
PLD
|
+$352M |
| 2 |
Merck
MRK
|
+$333M |
| 3 |
NVIDIA
NVDA
|
+$306M |
| 4 |
Atlassian
TEAM
|
+$280M |
| 5 |
Corteva
CTVA
|
+$253M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alnylam Pharmaceuticals
ALNY
|
+$3.41B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$331M |
| 3 |
iShares Russell 1000 Growth ETF
IWF
|
+$266M |
| 4 |
Danaher
DHR
|
+$240M |
| 5 |
TWTR
Twitter, Inc.
TWTR
|
+$237M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.56% |
| 2 | Healthcare | 14.16% |
| 3 | Financials | 12.95% |
| 4 | Consumer Discretionary | 9.76% |
| 5 | Industrials | 9.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
FBMS
2151
DELISTED
The First Bancshares, Inc.
FBMS
| $3.06M | ﹤0.01% |
95,465
+6,109
| +7% | +$198K |
|
2152
Opko Health
OPK
$1.02B
| $3.05M | ﹤0.01% |
2,441,064
+239,428
| +11% | +$377K |
|
|
SAFE
2153
Safehold
SAFE
$1.15B
| $3.04M | ﹤0.01% |
63,840
-10,695
| -14% | -$515K |
|
|
PNT
2154
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
| $3.01M | ﹤0.01% |
413,536
+150,424
| +57% | +$1.12M |
|
2155
Joby Aviation
JOBY
$8.55B
| $3.01M | ﹤0.01% |
695,875
-34,076
| -5% | -$138K |
|
2156
Ligand Pharmaceuticals
LGND
$6.36B
| $3.01M | ﹤0.01% |
44,994
-38,198
| -46% | -$2.48M |
|
2157
Adeia
ADEA
$3.11B
| $3M | ﹤0.01% |
316,999
-1,056,063
| -77% | -$10.7M |
|
2158
Fate Therapeutics
FATE
$326M
| $3M | ﹤0.01% |
297,483
+37,533
| +14% | +$705K |
|
2159
BlueLinx
BXC
$706M
| $2.99M | ﹤0.01% |
42,061
-4,277
| -9% | -$292K |
|
2160
Oscar Health
OSCR
$8.61B
| $2.98M | ﹤0.01% |
1,213,587
+580,220
| +92% | +$1.81M |
|
2161
Astec Industries
ASTE
$1.02B
| $2.98M | ﹤0.01% |
73,313
-10,021
| -12% | -$405K |
|
2162
Ichor Holdings
ICHR
$2.56B
| $2.98M | ﹤0.01% |
111,018
-19,508
| -15% | -$521K |
|
2163
Schrodinger
SDGR
$1.36B
| $2.96M | ﹤0.01% |
158,255
+1,008
| +0.6% | +$20.9K |
|
2164
Seaboard Corp
SEB
$4.06B
| $2.95M | ﹤0.01% |
782
+75
| +11% | +$283K |
|
2165
Douglas Dynamics
PLOW
$1.02B
| $2.95M | ﹤0.01% |
81,631
-23,279
| -22% | -$820K |
|
|
NVTA
2166
DELISTED
Invitae Corporation
NVTA
| $2.95M | ﹤0.01% |
1,586,113
+690,816
| +77% | +$1.69M |
|
2167
Arcus Biosciences
RCUS
$3.64B
| $2.94M | ﹤0.01% |
142,316
-24,359
| -15% | -$670K |
|
2168
Community Trust Bancorp
CTBI
$1.41B
| $2.93M | ﹤0.01% |
63,869
-7,280
| -10% | -$332K |
|
2169
Pitney Bowes
PBI
$2.39B
| $2.93M | ﹤0.01% |
771,838
-179,337
| -19% | -$604K |
|
2170
Resources Connection
RGP
$145M
| $2.93M | ﹤0.01% |
159,427
+35,285
| +28% | +$649K |
|
2171
Inogen
INGN
$164M
| $2.93M | ﹤0.01% |
148,493
+55,466
| +60% | +$1.19M |
|
2172
Hillman Solutions
HLMN
$1.79B
| $2.92M | ﹤0.01% |
404,961
-66,683
| -14% | -$501K |
|
|
PYCR
2173
DELISTED
Paycor HCM, Inc. Common Stock
PYCR
| $2.91M | ﹤0.01% |
118,990
+5,963
| +5% | +$165K |
|
2174
US Physical Therapy
USPH
$1.22B
| $2.91M | ﹤0.01% |
35,895
-2,274
| -6% | -$191K |
|
2175
Healthcare Services Group
HCSG
$1.53B
| $2.91M | ﹤0.01% |
242,178
-132,657
| -35% | -$1.75M |
|
Similar funds
VFT
Nuveen's Q4 2022 Portfolio in Review
As of Q4 2022, Nuveen held 3,329 positions worth $258B, up 4.5% from $247B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Nuveen withdrew a net $8.74B in Q4 2022, closing 159 positions and reducing 1,986 holdings. Its most notable exit was Twitter, Inc., an estimated $237M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Nuveen opened a new position in Atlassian worth $226M.
- Nuveen's largest Q4 2022 buy was Atlassian: 1,759,716 shares worth $226M.
- Nuveen added most to Prologis in Q4 2022, an estimated $352M increase.
- Nuveen's biggest Q4 2022 reduction was Alnylam Pharmaceuticals, cutting an estimated $3.41B.
- Nuveen fully exited Twitter, Inc. in Q4 2022, selling an estimated $237M.
- Nuveen's ten largest holdings make up 19% of its $258B portfolio in Q4 2022.
- Nuveen opened 40 new positions and closed 159 in Q4 2022.
- Nuveen's portfolio value rose 4.5% quarter-over-quarter to $258B.
Based on Nuveen's 13F filing for Q4 2022, filed 14 Feb 2023.